NON-ALCOHOLIC STEATOHEPATITIS
Clinical trials for NON-ALCOHOLIC STEATOHEPATITIS explained in plain language.
Never miss a new study
Get alerted when new NON-ALCOHOLIC STEATOHEPATITIS trials appear
Sign up with your email to follow new studies for NON-ALCOHOLIC STEATOHEPATITIS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Could a diabetes drug tame fatty liver disease?
Disease control OngoingThis study tests if semaglutide, a drug already used for diabetes, can help people with non-alcoholic steatohepatitis (NASH), a serious fatty liver disease. About 1205 adults with liver scarring but not cirrhosis will receive weekly injections of either semaglutide or a placebo f…
Matched conditions: NON-ALCOHOLIC STEATOHEPATITIS
Phase: PHASE3 • Sponsor: Novo Nordisk A/S • Aim: Disease control
Last updated Jun 15, 2026 18:56 UTC
-
New scanner aims to spot fatty liver without needles
Diagnosis TerminatedThis study was designed to test a new thermo-acoustic imaging device that may help diagnose fatty liver disease without invasive procedures. It would have compared the device's accuracy to standard MRI scans in adults aged 18-70 with known or suspected fatty liver. However, the s…
Matched conditions: NON-ALCOHOLIC STEATOHEPATITIS
Sponsor: Medical College of Wisconsin • Aim: Diagnosis
Last updated Jun 15, 2026 18:55 UTC